Charles W. Olson, Senior VP of Business Development, Med Development at SURMODICS INC (SRDX), sold 40,000 shares at $48.48 ($1.9M) on 2018-05-24, disclosed to the SEC on 2018-05-29.
Open-market sale of $1.9M SRDX by Senior VP of Business Development, Med Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.48 | 18,760 | $909K | 46.8% |
| 2 | $48.48 | 18,760 | $909K | 46.8% |
| 3 | $49.39 | 1,240 | $61K | 3.2% |
| 4 | $49.39 | 1,240 | $61K | 3.2% |
| Total | $48.54 avg | 40,000 | $1.9M | 100% |
| Filing → |
| SRDX | SELL | 2021-04-20 | $39K | — | Filing → |
| SRDX | SELL | 2021-04-02 | $540K | — | Filing → |
| SRDX | SELL | 2018-06-13 | $550K | — | Filing → |